QIPT

Quipt Home Medical Corp. provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market. The Company's expertise spans across a full spectrum of respiratory care, providing an end-to-end solution for medical providers and patients. This includes technology enabled equipment offerings and specialized care for patients with cardio and pulmonary diseases, sleep disorders, mobility challenges, and other chronic disease management. The Company's healthcare products and services include sleep apnea and pap treatment, home medical equipment, home ventilation and custom mobility solutions. It has a 60% ownership interest in Hart Medical Equipment, which maintains strategic relationships with integrated health systems and freestanding community-based hospitals, embedding the business into the hospital discharge processes of more than 19 hospitals and affiliated care facilities across its network.

Wall Street analysts forecast QIPT stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for QIPT is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Quipt Home Medical Corp revenue for the last quarter amounts to 58.29M USD, decreased -4.07 % YoY.

Quipt Home Medical Corp. EPS for the last quarter amounts to -0.07 USD, increased 75.00 % YoY.

Quipt Home Medical Corp (QIPT) has 1100 emplpoyees as of January 10 2026.

Today QIPT has the market capitalization of 156.30M USD.